Healthcare Providers and Services
Company Overview of InfuSystem Holdings, Inc.
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home i...
31700 Research Park Drive
Madison Heights, MI 48071
Founded in 2005
Key Executives for InfuSystem Holdings, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $507.0K
Chief Financial Officer and Executive Vice President
Total Annual Compensation: $368.2K
Chief Operating Officer and Executive Vice President
Total Annual Compensation: $363.1K
Compensation as of Fiscal Year 2014.
InfuSystem Holdings, Inc. Key Developments
InfuSystem Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Earnings Guidance for the Year 2015
Aug 13 15
InfuSystem Holdings, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net revenue of $17.170 million compared to $16.372 million a year ago. Operating income was $1.317 million compared to $2.338 million a year ago. Income before income taxes was $0.930 million compared to $1.602 million a year ago. Net income was $0.783 compared to $0.886 million a year ago. Net income per basic and diluted share was $0.03 compared to $0.04 a year ago. EBITDA was $3.259 million compared to $3.862 million a year ago. EBITDA - adjusted was $3.940 million compared to $3.992 million a year ago. Income before income taxes - adjusted was $1.281 million compared to $1.602 million a year ago. Net income - adjusted was $1.076 million compared to $881,000 a year ago.
For the six months, the company reported net revenue of $33.895 million compared to $33.614 million a year ago. Operating income was $2.869 million compared to $4.114 million a year ago. Income before income taxes was $0.230 million compared to $2.534 million a year ago. Net income was $0.368 million compared to $1.469 million a year ago. Net income per basic and diluted share was $0.02 compared to $0.07 a year ago. Adjusted EBITDA was $7.787 million compared to $7.320 million a year ago. EBITDA was $4.965 million compared to $7.048 million a year ago. Income before income taxes - adjusted was $2.435 million compared to $2.534 million a year ago. Net income - adjusted was $1.760 million compared to $1.470 million a year ago. Net cash provided by operating activities was $3.787 million compared to $1.806 a year ago. Purchase of medical equipment and property was $9.474 million compared to $4.524 a year ago. This increase in cash provided by operating activities was due to higher amounts of non-cash expenses (such as the loss on the extinguishment of debt, stock based compensation, depreciation and amortization) in the second quarter.
The company reaffirmed its 2015 guidance of double-digit net collected revenue growth for fiscal year 2015.
InfuSystem Holdings Seeks Acquisitions
Aug 13 15
InfuSystem Holdings, Inc. (AMEX:INFU) is looking for acquisitions. Jonathan P. Foster, Chief Financial Officer said, "Interest expense for the second quarter of 2015 was reduced by 50% as a function of the refinancing of our credit facility, with JP Morgan Chase, in the previous quarter. The new credit facility enables us to run our business in a highly efficient manner while allowing us to take advantage of acquisition opportunities, such as Ciscura, as they present themselves. We are very pleased in that regard. During the quarter we made a $1.0 million pre-payment on our Term Loan A with Chase to get ahead of the curve in maintaining a prudent debt structure that will allow us to grow the Company effectively while responsibly servicing that debt and driving value for our shareholders. The first payment of Term Loan A would have been due on September 30, 2015."
InfuSystem Holdings, Inc. to Report Q2, 2015 Results on Aug 13, 2015
Aug 6 15
InfuSystem Holdings, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 13, 2015
Similar Private Companies By Industry
Recent Private Companies Transactions